Coversin

Drug identity checked against registry records

Also recorded as rEV576; rVA576

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)NCT02591862AKARI TherapeuticsPhase 2Completed2018-03-20Actual
Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 PolymorphismsNCT03427060AKARI TherapeuticsPhase 2Completed2018-11-15Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.